Contraindicated in:
Use Cautiously in:
CV: pulmonary edema (↑ in veno-occlusive disease), hypotension.
GI: dyspepsia, gastritis, nausea, vomiting, constipation, diarrhea, gastroesophageal reflux, ↑ liver enzymes.
Hemat: BLEEDING, anemia.
Drug-Drug:
Drug-Natural Products:
Therapeutic Classification:pulmonary hypertension agents
Pharmacologic Classification: soluble guanylate cyclase stimulators (sGS)
Absorption: Well absorbed following oral administration (94%).
Distribution: Unknown.
Protein Binding: 95%.
Metabolism/Excretion: Extensively metabolized (by CYP1A1, CYP3A, CYP2C8, and CYP2J2); M1 metabolite is pharmacologically active; metabolites are excreted in urine and feces (great individual variation).
Half-life: 12 hr.